/Investor DB

Lake Bleu Capital — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Singleron Biotechnologiessingleronbio.comin𝕏Nov 2021

Singleron Biotechnologies develops single-cell and single-nucleus sequencing kits and solutions for transcriptome analysis of biological samples.

BiotechMedical DevicesCologne, DE

Nan Fang(PhD, MBA; CEO and Founder)inJing Zhou(PhD; CSO (co-founder))inRong Fan(Co-Founder of Singleron, Professor Yale University)in

Co-investorsARCH Venture PartnersLAVLilly Asia VenturesMSA CapitalSBCVCSherpa Healthcare Partners+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.